JOURNAL DESCRIPTION

The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.

Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.

Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.

The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.

Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.

The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.

Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.

The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.

Issues journals

Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 2. P. 68–81

B.Ya. Narkevich1,2, A.V. Khmelev3,4, V.V. Krylov5, T.Yu. Kochetova5

Development of a Concise Glossary of Nuclear Medicine Terms

1 N.N. Blokhin National Medical Research Center for Oncology, Ministry of Health of Russia, Moscow, Russia
2 Association of Medical Physicists of Russia, Moscow, Russia
3 Research Institute — Republican Research Scientific and Consulting Center for Expertise, Moscow, Russia
4 Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia, Moscow, Russia
5 A. Tsyb Medical Radiological Research Center — branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Obninsk, Kaluga region, Russia

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract

The development of domestic nuclear medicine necessitates the development and systematization of the most frequently used terms with scientifically based interpretation of their respective concepts. It is important to ensure the correct and unambiguous interpretation of the terms not only by professionals in the field of nuclear medicine, but also by specialists in related fields of knowledge. A short glossary of terms in nuclear medicine is presented, which contains all the most frequently used terms in this field and explanations for each of them, adapted for all the above specialists.

Key words: nuclear medicine, terminology, glossary

For citation: Narkevich BYa, Khmelev AV, Krylov VV, Kochetova TYu. Development of a Concise Glossary of Nuclear Medicine Terms. Medical Radiology and Radiation Safety. 2020;65(2):68-81. (In Russ.).

DOI: 10.12737/1024-6177-2020-65-2-68-81

References

  1. Наркевич БЯ, Ратнер ТГ, Моисеев АН. Краткий словарь дискуссионных терминов по медицинской радиологии, радиационной безопасности и медицинской физике. Медицинская радиология и радиационная безопасность 2018;63(5):55-64. DOI: 10.12737/article_5bc89734df8824.31259760. [Narkevich BYa, Ratner TG, Moiseev AN. Brief dictionary of discussion terms on medical radiology, radiation safety and medical physics. Medical Radiology and Radiation Safety. 2018;63(5):55-64. (in Russ.)].

PDF (RUS) Full-text article (in Russian)

ORCID authors’

B.Ya. Narkevich http://orcid.org/0000-0002-4293-7358
A.V. Khmelev https://orcid.org/0000-0002-5808-1507
V.V. Krylov https://orcid.org/0000-0001-6655-5592
T.Yu. Kochetova https://orcid.org/0000-0002-7809-1059

Conflict of interest. The authors declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Article was prepared with equal participation of the authors.

Article received: 12.02.2020.

Accepted for publication: 12.03.2020.

Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 2. P. 82–86

A.D. Ryzhkov1, A.S. Krylov1, A.B. Bludov1, A.V. Kuzin2, S.M. Kaspshik1, M.B. Dolgushin1

Evaluation of the SPECT/CT Method in the Diagnosis of Alkaptonuric Ochronosis. Clinical Case

1 N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia
2 Russian Medical Academy of Continuous Professional Education, Moscow, Russia

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract

Purpose: Is to demonstrate functional and structural changes in the musculoskeletal system of the patient with alkaptonuric ochronosis using bone scan and hybrid imaging consisting of single-photon emission computed tomography (SPECT) and X-ray transmission computed tomography (CT) scan (SPECT/CT).

Material and methods: A clinical case report of patient with alkaptonuric ochronosis, examined with bone scan and SPECT/CT.

Results: In this article we show a clinical case with the picture of mineral metabolism disorder and severe degenerative changes of musculoskeletal system in patient with alkaptonuric ochronosis (a genetically determined disease), caused by metabolic disorders of tyrosine. We used hybrid SPECT/CT method for evaluation of this disease.

Conclusion: SPECT/CT method demonstrated structural and metabolic changes. This method allowed us to reveal the specific changes in cases of alkaptonuric ochronosis, but also it shows the possibility of using radionuclide methods in solving non-standard situations, while this method has not previously been applied.

Key words: alkaptonuria, ochronosis, bone scan, SPECT/CT

For citation: Ryzhkov AD, Krylov AS, Bludov AB, Kuzin AV, Kaspshik SM, Dolgushin MB. Evaluation of the SPECT/CT Method in the Diagnosis of Alkaptonuric Ochronosis. Clinical Case. Medical Radiology and Radiation Safety. 2020;65(2):82-6. (In Russ.).

DOI: 10.12737/1024-6177-2020-65-2-82-86

References

  1. Mannoni A, Selvi E, Lorenzini S, Giorgi M, Airó P, Cammelli D, Andreotti L, Marcolongo R, Porfirio B. Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum. 2004;33(4):239-48. DOI: 10.1053/s0049-0172(03)00080-5.
  2. Zatkova A. An update on molecular genetics of Alkaptonuria (AKU). J Inherit Metab Dis. 2011;34(6):1127-36. DOI: 10.1007/s10545-011-9363-z.
  3. Taylor AM, Boyde A, Wilson PJ, Jarvis JC, Davidson JS, Hunt JA, Ranganath LR, Gallagher JA. The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum. 2011;63(12):3887-96. DOI: 10.1002/art.30606.
  4. Araki K, Sudo A, Hasegawa M, Uchida A. Devastating ochronotic arthropathy with successful bilateral hip and knee arthroplasties. J Clin Rheumatol. 2009;15(3):138-40. DOI: 10.1097/RHU.0b013e31819e6b41.
  5. Aquaron R. Alkaptonuria: a very rare metabolic disorder. Indian J Biochem Biophys. 2013;50(5):339-44.
  6. Gallagher JA, Dillon JP, Sireau N, Timmis O, Ranganath LR. An example of a “fundamental disease” — A rare disease with important lessons for more common disorders. Semin Cell Dev Biol. 2016;52:53-7. DOI: 10.1016/j.semcdb.2016.02.020.
  7. Perrone A, Impara L, Bruni A, Primicerio P, Marini M. Radiographic and MRI findings in ochronosis. Radiol Med. 2005;110(4):349-58.
  8. Doganavsargil B, Pehlivanoglu B, Bicer EK, Argin M, Bingul KB, Sezak M, et al. Black joint and synovia: histopathological evaluation of degenerative joint disease due to ochronosis. Pathol Res Pract. 2015;21(6);470-7. DOI: 10.1016/j.prp.2015.03.001.
  9. Ranganath LR, Cox TF Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis. 2011;34 (6):1141-51. DOI: 10.1007/s10545-011-9374-9.
  10. Насонова ВА, Бунчук НВ. Руководство для врачей. Ревматические болезни. М.: Медицина. 1997. 520 с. [Nasonova VA, Bunchuk NV (Ed.) Rheumatic Diseases: A Guide for Physicians. M.: Medicine. 1997. 520 p. (in Russ.)].
  11. Клипелл ДХ, Стоун ДХ, Кроффорд ЛДж, Уайт ПХ. Рев­ма­тические заболевания. Руководство в 3 т. Т.2. Заболевания костей и суставов. Под ред. Насонова ЕЛ, Насонова ВА, Олюнина ЮА. (перевод). М.: ГЭОТАР-Медиа. 2012. 520 с. [Clipell DH, Stone DH, Crofford LJ, White PH. Ed by Nasonov EL, Nasonov VA, Olyunin YuA (trans). Rheumatic Diseases. Manual in 3 vol. Vol. 2. Bone and Joint Diseases. M.: GEOTAR-Media, 2012. 520 p. (in Russ.)].
  12. Башкова ИБ, Кичигин ВА, Безлюдная НВ и др. Охроноз: труд­ности постановки диагноза в практике врача-клини­цис­та. Трудный пациент. 2016;14(10-11):40-5. [Bashkova IB, Kichigin VA, Bezludnaya NV, Stepanov EG, Kovalev DV, Karpuhin AS, Tarasov AN. Ochronosis: difficulties in diagnosing in clinician’s practice. Difficult Patient. 2016;14(10-11):40-5. (in Russ.)].
  13. Чепой ВМ. Диагностика и лечение болезней суставов. М.: Медицина. 1990. 304 с. [Chepoy VM. Diagnosis and Treatment of Diseases of the Joints. M.: Medicine. 1990. 304 p. (in Russ.)].
  14. Григоровский ВВ, Бабко АН. Дифференциальная диагностика и лечение охронотической артропатии (описание клиничес­ко­го случая и современное состояние вопроса). Вестник травма­тологии и ортопедии им. Н.Н. Приорова. 2006;(4):42-8. [Grigorovskiy VV, Babko AN. Differential Diagnosis and Treatment of Ochronotic Arthropathy. (Case report and current state review). N.N. Priorov Bulletin of Traumatology and Ortopedics. 2006;(4):42-8. (in Russ.)].
  15. Ventura-Ríos L, Hernández-Díaz C, Gutiérrez-Pérez L, Bernal-González A, Pichardo-Bahena R, Cedeño-Garcidueñas AL, Pineda C. Ochronotic arthropathy as a paradigm of metabolically induced degenerative joint disease. A case-based review. Clin Rheumatol. 2016;35(5):1389-95. DOI: 10.1007/s10067-014-2557-7.
  16. Башкова ИБ, Кичигин ВА, Шаипов РШ и др. Охроноз как причина вторичного остеоартроза. РМЖ. 2017;25(7):474-80. [Bashkova IB, Kichigin VA, Shaipov RSh, Kryuchkov NA, Bezlyudnaya NV, Didichenko SN, Borisova LV. Ochronosis as a cause of secondary osteoarthrosis. RMJ. 2017;25(7):474-80. (in Russ.)].
  17. Золовкина АГ, Супрун ЕА, Джухаев ДА и др. Алкаптону­рический охроноз при эндопротезировании крупных суставов. Лабораторная служба. 2018;7(3-2):95. [Zolovkina AG, Suprun EA, Dzhukhaev DA, Lobanov MN, Abdaljan AM. Alkaptonuric ochronosis in endoprosthesis replacement of large joints. Laboratory Service. 2018;7(3-2):95. (in Russ.)].
  18. Zhao BH, Chen BC, Shao DC, Zhang Q Osteoarthritis? Ochronotic arthritis! A case study and review of the literature. Knee Surg Sports Traumatol Arthrosc. 2009;17(7):778-81. DOI: 10.1007/s00167-009-0778-0.
  19. Авдеева ОС, Беляева ЕА, Дубровина ЮС и др. Вторичный остеоартроз при охронозе в сочетании с остеопорозом. Вестник новых медицинских технологий. 2008;15 (3):90-1. [Avdeeva OS, Belyaeva EA, Dubrovina YuS, Nikishina OA, Savenkova NA, Yushina TA. Secondary osteoarthritis in case of ochronosis combined with osteoporosis. Journal of New Medical Technologies. 2008;15 (3):90-1. (in Russ.)].
  20. Чернов ВИ, Брагина ОД, Синилкин ИГ и др. Радио­нуклид­ная тераностика злокачественных образований. Вестник рентгенологии и радиологии. 2016;97(5):306-13. [Chernov VI, Bragina OD, Sinilkin IG, Medvedeva AA, Zel’chan RV. Radionuclide teranostic of malignancies. Journal of Radiology and  Nuclear  Medicine. 2016;97(5):306-13. (in Russ.)].
  21. Крылов АС, Рыжков АД, Щипахина ЯА и др. Роль ОФЭКТ/КТ и МРТ в дифференциальной диагностике поражения скелета (клинический случай). Медицинская радиология и радиационная безопасность. 2019;64(1):69-73. [Krylov AS, Ryzhkov AD, Shchipakhina YA, Nered AS, Bludov AB, Shiryaev SV. The role of SPECT/CT and MRI in the differential diagnosis of skeletal damage (case report). Medical Radiology and Radiation Safety. 2019;64(1):69-73. (in Russ.)]. DOI: 10.12737/article_5c55fb5ef00a68.52703915.
  22. Рыжков АД, Крылов АС, Блудов АБ, Ширяев СВ. Остео­сцин­тиграфия и ОФЭКТ/КТ в диагностике различных ва­риантов метастатического поражения костей. Меди­цинс­кая радиология и радиационная безопасность. 2018;63(2):41-6. [Ryzhkov AD, Krylov AS, Bludov AB, Shiryaev SV Osteoscintigraphy and SPECT/CT in the diagnosis of various variants of bone metastases. Medical Radiology and Radiation Safety. 2018;63(2):41-6. (in Russ.)]. DOI: 10.12737/article_5ac61fd62feba6.78437892.
  23. Чернов ВИ, Брагина ОД, Синилкин ИГ и др. Радио­имму­нотерапия: современное состояние проблемы. Вопросы онкологии. 2016;62(1):24-30. [Chernov VI, Bragina OD, Sinilkin IG, Medvedeva AA, Zelchan RV. Radioimmunotherapy: Current state of the problem. Problems of Oncology. 2016;62(1):24-30. (in Russ.)].
  24. Рыжков АД, Крылов АС, Ширяев СВ. Преимущество ком­би­нированной ОФЭКТ/КТ в диагностике метастазов в костях. Медицинская радиология и радиационная безо­пас­ность. 2017;62(5):33-9. [Ryzhkov AD, Krylov AS, Shiryaev SV, Shchipakhina YaA, Kochergina NV. The advantage of a combined SPECT/CT in the diagnosis of bone metastases. Medical Radiology and Radiation Safety. 2017;62(5):33-9. (in Russ.)]. DOI: 10.12737/article_59f2fc0812bc46.45377149.
  25. Chernov VI, Triss SV, Skuridin VS, Lishmanov YB Thallium-199: A new radiopharmaceutical for myocardial perfusion imaging. Int J Card Imaging 1996;12(2):119-26.
  26. Lishmanov Y, Minin S, Efimova I, Chernov V, Saushkina Y, Lebedev D, Popov S. The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure. Ann Nucl Med. 2013;27(4):378-85.

PDF (RUS) Full-text article (in Russian)

ORCID authors’

Ryzhkov A.D., http://orcid.org/0000-0002-9571-801X
Krylov A.S., http://orcid.org/0000-0002-8476-7879
Bludov A.B., https://orcid.org/0000-0002-0970-6144
Kuzin A.V., http://orcid.org/0000-0002-1262-932Х
Kaspshik S.M., http://orcid.org/0000-0002-1384-9551
Dolguyshin M.B., http://orcid.org/0000-0003-3930-5998

Conflict of interest. The authors declare no conflict of interest.

Informed consent. All patients signed an informed consent to participate in the study.

Financing. The study had no sponsorship.

Contribution. Article was prepared with equal participation of the authors.

Article received: 21.01.2020

Accepted for publication: 12.03.2020.

Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 2. P. 88

Commemoration of E.K. Vasilenko

PDF (RUS) Full-text article (in Russian)

Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 2. P. 87

Commemoration of R.V. Arutyunyan

PDF (RUS) Full-text article (in Russian)

Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 3. P. 5–12

I.V. Ivanov1,2, I.B. Ushakov3

Basic Approaches to the Extrapolation of Data of Animals to Human in Radiobiological Experiment

1 I.M. Sechenov First Moscow State Medical University, Moscow, Russia, This email address is being protected from spambots. You need JavaScript enabled to view it.
2 State Scientific Research Institute of the Military Medicine, Saint-Petersburg, Russia
3 A.I. Burnasyan Federal Medical Biophysical Center, Moscow, Russia

Abstract

Purpose: Substantiate the main directions of transferring experimental data from laboratory animals to humans.

Methods: The general patterns of the structure of the organism of animals and humans and the dynamics of the processes of their vital activity, including under the influence of various environmental factors, as well as the tendency of their approximation in the evolutionary series from lower mammals to humans are considered.

Results: The choice of criteria and methods for assessing the state of the human body and comparison with those in animals in simulated situations is systematized according to 3 main levels – physiological-biochemical, neuropsychological and social. Parameters of physiological reactions, clinical laboratory and biochemical parameters are assigned to level 1, parameters characterizing the functions of higher nervous activity, neurodynamic reactions, targeted actions and psychological manifestations to level 2, characteristics of interpersonal interactions to level 3. The types, tasks and methods of research that are carried out on small rodent animals (screening) and on larger animals from other mammalian orders that are closer in terms of evolutionary development and other parameters to humans (in-depth) are considered.

Conclusion: It is shown that when comparing the results of studies obtained in animal experiments and in human observations, it is important to use coefficients for the quantitative transfer of data from animals to humans, which require careful substantiation taking into account the interspecific characteristics of mammals and humans.

Key words: radiobiology, biomedical experiment, laboratory animals, extrapolation coefficients, parameters of physiological reactions, clinical and laboratory indicators, higher nervous activity, neurodynamic reactions, interpersonal interactions

For citation: Ivanov IV, Ushakov IB. Basic Approaches to the Extrapolation of Data of Animals to Human in Radiobiological Experiment. Medical Radiology and Radiation Safety. 2020;65(3):5-12. (In Russ.).

DOI: 10.12737/1024-6177-2020-65-3-5-12

References

1. Даренская Н.Г. Сопоставление зависимости доза-эффект для разных видов животных и значение этих данных для человека. В сб.: Радиобиологический эксперимент и человек. М.: Атомиздат; 1970. С. 50-62. [Darenskaya NG. Comparison of dose-effect relationships for different species of animals and the significance of these data for humans. In: Radiobiological experiment and humans. Moscow. 1970:50-62. (In Russ.)].
2. Даренская Н.Г., Ушаков И.Б., Иванов И.В., Иванченко А.В., Насонова Т.А. От эксперимента на животных – к человеку: поиски и решения. Воронеж: Научная книга. 2010. 237 с. [Darenskaya NG, Ushakov IB, Ivanov IV, Ivanchenko AV, Nasonova TA. From experiment on animals – to the person: searches and decisions. Voronezh. 2010. (In Russ.)].
3. Красовский Г.Н., Рахманин Ю.А., Егорова Н.А. Экстраполяция токсикологических данных с животных на человека. М.: ОАО «Издательство «Медицина», 2009. 208 с. [Krasovsky GN, Yegorova NA, Rakhmanin YuA. Extrapolation of toxicological data from animals to humans. Moscow. 2009. (In Russ.)].
4. Анохин П.К. Биология и нейрофизиология условного рефлекса. – М.: Медицина; 1968. 547 с. [Anokhin PK. Biology and neurophysiology of the conditioned reflex. Moscow. 1968. (In Russ.)].
5. Becker RA, Ankley GT, Edwards SW, Kennedy SW, Linkov I, Meek B, et al. Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence. Regulatory Toxicology and Pharmacology. 2015;72:514-37.
DOI: 10.1016/j.yrtph.2015.04.004.
6. Becker RA, Dellarco V, Seed J, Kronenberg JM, Meek B, Foreman J, et al. Quantitative weight of evidence to assess confidence in potential modes of action. Regulatory Toxicology and Pharmacology. 2017;86:205-20. DOI: 10.1016/j.yrtph.2017.02.017.
7. Boobis AR, Doe JE, Meek ME(Bette), Munn Sh, Ruchirawat M, Schlatter J, et al. IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans. Critical Reviews in Toxicology. 2008;38:87-96. DOI: 10.1080/10408440701749421.
8. Slikker WJr, Andersen ME, Bogdanffy MS, Bus JS, Cohen SD, Conolly RB, et al. Dose-dependent transitions in mechanisms of toxicity. Toxicol Appl Pharmacol. 2004;201(3):203-25. DOI: 10.1016/j.taap.2004.06.019.
9. Seed J, Carney EdW, Corley RA, Crofton KM, DeSesso JM, Foster PMD, et al. Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data. Critical Reviews in Toxicology. 2005;35:663-72. DOI: 10.1080/10408440591007133.
10. Meek ME, Boobis A, Cote I, Dellarco V, Fotakis G, Munn S, et al. New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis. J Appl Toxicol. 2014;34(1):1-18. DOI: 10.1002/jat.2949.
11. Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, et al. IPCS Conceptual Framework for Evaluating a Mode of Action for Chemical Carcinogenesis. Regulatory Toxicology and Pharmacology. 2001;34:146-52. DOI:10.1006/rtph.2001.1493.
12. Meek ME(Bette), Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, et al. A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action. Critical Reviews in Toxicology. 2003;33(6):591-653. DOI: 10.1080/10408440390250136.
13. Becker RA, Patlewicz G, Simon TW, Rowlands JC, Budinsky RA. The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor. Regulatory Toxicology and Pharmacology. 2015;73:172-90. DOI: 10.1016/j.yrtph.2015.06.015
14. Lynch HN, Loftus CT, Cohen JM, Kerper LE, Kennedy EM, Goodman JE. Weight-of-evidence evaluation of associations between particulate matter exposure and biomarkers of lung cancer. Regulatory Toxicology and Pharmacology. 2016;82:53-93. DOI: 10.1016/j.yrtph.2016.10.006.
15. Иванов И.В. Методики оценки работоспособности лабораторных животных при экспериментальном воздействии патогенных и экстремальных факторов. Военно-медицинский журнал. 2012;333(2):42-7 [Ivanov IV. Methods of evaluation of efficiency of laboratory animals in the experimental influence of pathogenic and extreme factors. Military Medical Journal. 2012;333(2):42-7. (In Russ.)].
16. Шустов Е.Б., Каркищенко Н.Н., Уйба В.В., Каркищенко В.Н. Очерки спортивной фармакологии. Т. 1. Векторы экстраполяции. СПб.: ООО «Айсинг». 2013. 288 с. [Shustov EB, Karkischenko NN, Uiba VV, Karkischenko VN. Sketches of sports pharmacology. Vol. 1. Extrapolation vectors. Saint Petersburg. 2013. (In Russ.)].
17. Ушаков И.Б., Штемберг А.С., Шафиркин А.В. Реактивность и резистентность организма млекопитающих. – М.: Наука, 2007. 493 с. [Ushakov IB, Shtemberg AS, Shafirkin AV. Reactivity and resistance mammalian organism. Moscow. 2007. (In Russ.)].
18. Иванов И.В. Исходная реактивность организма и радиационные воздействия: лечебно-профилактические аспекты проблемы. Научно-практическое руководство. М. 2005. 394 с. [Ivanov IV. Initial reactivity of organism and radiation effects: medical-prophylactic aspects of the problem. Moscow. 2005. (In Russ.)].

PDF (RUS) Full-text article (in Russian)

Conflict of interest. The authors declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Article was prepared with equal participation of the authors.

Article received: 11.09.2019.

Accepted for publication: 24.06.2020.

Contact Information

 

46, Zhivopisnaya st., 123098, Moscow, Russia Phone: +7 (499) 190-95-51. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Journal location

Attendance

2769956
Today
Yesterday
This week
Last week
This month
Last month
For all time
2902
2948
25438
25438
77699
75709
2769956

Forecast today
2832


Your IP:216.73.216.59